Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    MO07 - NSCLC - Targeted Therapies II

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 14
    • Moderators:T. John
    • Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
    • +

      MO07.09 - Feasibility and clinical impact of re-biopsy in advanced non-small cell lung cancer: a prospective multicentric study in real world setting (GFPC study 12-01)

      17:00 - 17:05  |  Author(s): C. Dujon

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.09 - Poster Session 2 - Combined Modality

    • Type: Poster Session
    • Track: Combined Modality
    • Presentations: 18
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.09-001 - Phase II study of concurrent chemo-radiotherapy (CRT) with weekly cisplatinum plus oral vinorelbine in fit elderly patients with nonresectable locally advanced non-small-cell lung cancer (NSCLC) assessed by Standardized Geriatric Assessment (RACCOSA, GFPC 08-06 study): interim analysis.

      09:30 - 09:30  |  Author(s): C. Locher

      • Abstract

      Loading...

  • +

    P2.10 - Poster Session 2 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 52
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.10-013 - Randomized non comparative multicenter phase II study of sequential erlotinib with docetaxel versus docetaxel alone in patients with non small cell lung cancer (NSCLC) after failure of first line chemotherapy (TARSEQ): a GFPC 10.02 study.

      09:30 - 09:30  |  Author(s): J.B. Auliac

      • Abstract

      Loading...

  • +

    P2.22 - Poster Session 2 - Epidemiology, Etiology

    • Type: Poster Session
    • Track: Prevention & Epidemiology
    • Presentations: 13
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.22-004 - Survival improvement in primary lung cancer patients in a 10-year period: results of the French KBP-2000-CPHG and KBP-2010-CPHG cohorts

      09:30 - 09:30  |  Author(s): C. Locher

      • Abstract

      Loading...

  • +

    P3.10 - Poster Session 3 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 55
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.10-041 - Impact of a Comprehensive Geriatric Assessment on management strategies in elderly patients with advanced no small cell lung cancer (NSCLC): a polled analysis of two phase 2 prospective study of the GFPC group.

      09:30 - 09:30  |  Author(s): I. Borget

      • Abstract

      Loading...